Actively Recruiting
Efficacy of Acetaminophen Alone Versus Combination of Acetaminophen/Ibuprofen After Cesarean Section
Led by Seoul National University Hospital · Updated on 2025-06-04
84
Participants Needed
1
Research Sites
97 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators aim to compare the analgesic efficacy of intravenous acetaminophen alone versus combination of acetaminophen/ibuprofen (Maxigesic®IV) in multimodal analgesia after cesarean section.
CONDITIONS
Official Title
Efficacy of Acetaminophen Alone Versus Combination of Acetaminophen/Ibuprofen After Cesarean Section
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients scheduled for elective cesarean section
- Gestational age greater than 37 weeks
You will not qualify if you...
- Emergency cesarean section
- Multiple pregnancy (e.g. twins, triplets)
- Body weight less than 50 kg
- Preeclampsia
- History of hypersensitivity to acetaminophen or ibuprofen
- History of upper gastrointestinal tract bleeding or gastric ulcer
- Underlying liver disease
- Underlying kidney disease or GFR less than 90 mL/min/1.73m2
- Heart failure or severe hypertension
- History of asthma
- Chronic use of barbital or tricyclic antidepressants
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National University Hospital
Seoul, South Korea, 03080
Actively Recruiting
Research Team
H
Hansol Kim, MD
CONTACT
J
Junghwa Seo, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here